• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

数学建模作为骨髓增殖性肿瘤作为癌症发展的人类炎症模型的概念验证。

Mathematical modelling as a proof of concept for MPNs as a human inflammation model for cancer development.

作者信息

Andersen Morten, Sajid Zamra, Pedersen Rasmus K, Gudmand-Hoeyer Johanne, Ellervik Christina, Skov Vibe, Kjær Lasse, Pallisgaard Niels, Kruse Torben A, Thomassen Mads, Troelsen Jesper, Hasselbalch Hans Carl, Ottesen Johnny T

机构信息

Department of Science and Environment, Roskilde University, Roskilde, Denmark.

Department of Laboratory Medicine at Boston Children's Hospital, Boston, Massachusetts, United States of America.

出版信息

PLoS One. 2017 Aug 31;12(8):e0183620. doi: 10.1371/journal.pone.0183620. eCollection 2017.

DOI:10.1371/journal.pone.0183620
PMID:28859112
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5578482/
Abstract

The chronic Philadelphia-negative myeloproliferative neoplasms (MPNs) are acquired stem cell neoplasms which ultimately may transform to acute myelogenous leukemia. Most recently, chronic inflammation has been described as an important factor for the development and progression of MPNs in the biological continuum from early cancer stage to the advanced myelofibrosis stage, the MPNs being described as "A Human Inflammation Model for Cancer Development". This novel concept has been built upon clinical, experimental, genomic, immunological and not least epidemiological studies. Only a few studies have described the development of MPNs by mathematical models, and none have addressed the role of inflammation for clonal evolution and disease progression. Herein, we aim at using mathematical modelling to substantiate the concept of chronic inflammation as an important trigger and driver of MPNs.The basics of the model describe the proliferation from stem cells to mature cells including mutations of healthy stem cells to become malignant stem cells. We include a simple inflammatory coupling coping with cell death and affecting the basic model beneath. First, we describe the system without feedbacks or regulatory interactions. Next, we introduce inflammatory feedback into the system. Finally, we include other feedbacks and regulatory interactions forming the inflammatory-MPN model. Using mathematical modeling, we add further proof to the concept that chronic inflammation may be both a trigger of clonal evolution and an important driving force for MPN disease progression. Our findings support intervention at the earliest stage of cancer development to target the malignant clone and dampen concomitant inflammation.

摘要

慢性费城染色体阴性骨髓增殖性肿瘤(MPNs)是获得性干细胞肿瘤,最终可能转化为急性髓系白血病。最近,慢性炎症被描述为MPNs从早期癌症阶段到晚期骨髓纤维化阶段的生物学连续过程中发生和进展的一个重要因素,MPNs被称为“癌症发展的人类炎症模型”。这一新颖概念是建立在临床、实验、基因组、免疫学尤其是流行病学研究基础之上的。只有少数研究通过数学模型描述了MPNs的发生,且没有一项研究探讨炎症在克隆进化和疾病进展中的作用。在此,我们旨在利用数学建模来证实慢性炎症是MPNs重要触发因素和驱动因素这一概念。该模型的基本原理描述了从干细胞到成熟细胞的增殖过程,包括健康干细胞突变为恶性干细胞。我们纳入了一个简单的炎症耦合机制,以应对细胞死亡并影响其下的基本模型。首先,我们描述无反馈或调节相互作用的系统。接下来,我们将炎症反馈引入该系统。最后,我们纳入其他反馈和调节相互作用,形成炎症-MPN模型。通过数学建模,我们进一步证明了慢性炎症可能既是克隆进化的触发因素,也是MPN疾病进展的重要驱动力这一概念。我们的研究结果支持在癌症发展的最早阶段进行干预,以靶向恶性克隆并减轻伴随的炎症。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/036a/5578482/0aaf773aae52/pone.0183620.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/036a/5578482/f30fafd8d4cf/pone.0183620.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/036a/5578482/83a30bf72709/pone.0183620.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/036a/5578482/f790f4533949/pone.0183620.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/036a/5578482/341d4253cb2e/pone.0183620.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/036a/5578482/0aaf773aae52/pone.0183620.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/036a/5578482/f30fafd8d4cf/pone.0183620.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/036a/5578482/83a30bf72709/pone.0183620.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/036a/5578482/f790f4533949/pone.0183620.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/036a/5578482/341d4253cb2e/pone.0183620.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/036a/5578482/0aaf773aae52/pone.0183620.g005.jpg

相似文献

1
Mathematical modelling as a proof of concept for MPNs as a human inflammation model for cancer development.数学建模作为骨髓增殖性肿瘤作为癌症发展的人类炎症模型的概念验证。
PLoS One. 2017 Aug 31;12(8):e0183620. doi: 10.1371/journal.pone.0183620. eCollection 2017.
2
Chronic inflammation as a promotor of mutagenesis in essential thrombocythemia, polycythemia vera and myelofibrosis. A human inflammation model for cancer development?慢性炎症作为原发性血小板增多症、真性红细胞增多症和骨髓纤维化中突变的促进因素。一种人类炎症模型与癌症发展有关?
Leuk Res. 2013 Feb;37(2):214-20. doi: 10.1016/j.leukres.2012.10.020. Epub 2012 Nov 20.
3
A role of NF-E2 in chronic inflammation and clonal evolution in essential thrombocythemia, polycythemia vera and myelofibrosis?NF-E2 在原发性血小板增多症、真性红细胞增多症和骨髓纤维化中的慢性炎症和克隆进化中的作用?
Leuk Res. 2014 Feb;38(2):263-6. doi: 10.1016/j.leukres.2013.07.002. Epub 2013 Aug 9.
4
JAK2 and genomic instability in the myeloproliferative neoplasms: a case of the chicken or the egg?JAK2 与骨髓增殖性肿瘤的基因组不稳定性:先有鸡还是先有蛋?
Am J Hematol. 2012 Nov;87(11):1028-36. doi: 10.1002/ajh.23243. Epub 2012 May 28.
5
New Strategies in Myeloproliferative Neoplasms: The Evolving Genetic and Therapeutic Landscape.骨髓增殖性肿瘤的新策略:不断演变的遗传与治疗格局
Clin Cancer Res. 2016 Mar 1;22(5):1037-47. doi: 10.1158/1078-0432.CCR-15-0905.
6
Increase in Frequency of Myeloid-Derived Suppressor Cells in the Bone Marrow of Myeloproliferative Neoplasm: Potential Implications in Myelofibrosis.骨髓增生性肿瘤患者骨髓中髓源性抑制细胞频率增加:在骨髓纤维化中的潜在影响。
Adv Exp Med Biol. 2023;1408:273-290. doi: 10.1007/978-3-031-26163-3_15.
7
Genotype-phenotype interactions in the myeloproliferative neoplasms.骨髓增殖性肿瘤中的基因型-表型相互作用。
Hematol Oncol Clin North Am. 2012 Oct;26(5):993-1015. doi: 10.1016/j.hoc.2012.07.003. Epub 2012 Aug 28.
8
The spectrum of JAK2-positive myeloproliferative neoplasms.JAK2 阳性骨髓增殖性肿瘤谱。
Hematology Am Soc Hematol Educ Program. 2012;2012:561-6. doi: 10.1182/asheducation-2012.1.561.
9
Perspectives on chronic inflammation in essential thrombocythemia, polycythemia vera, and myelofibrosis: is chronic inflammation a trigger and driver of clonal evolution and development of accelerated atherosclerosis and second cancer?原发性骨髓纤维化、真性红细胞增多症和原发性血小板增多症中慢性炎症的观点:慢性炎症是克隆进化以及加速动脉粥样硬化和第二癌症发展的触发因素和驱动因素吗?
Blood. 2012 Apr 5;119(14):3219-25. doi: 10.1182/blood-2011-11-394775. Epub 2012 Feb 7.
10
Driver mutations (JAK2V617F, MPLW515L/K or CALR), pentraxin-3 and C-reactive protein in essential thrombocythemia and polycythemia vera.原发性血小板增多症和真性红细胞增多症中的驱动突变(JAK2V617F、MPLW515L/K或CALR)、五聚体蛋白3和C反应蛋白。
J Hematol Oncol. 2017 Feb 22;10(1):54. doi: 10.1186/s13045-017-0425-z.

引用本文的文献

1
Stem cell graft dose and composition could impact on the expansion of donor-derived clones after allogeneic hematopoietic stem cell transplantation - a virtual clinical trial.干细胞移植剂量和组成可能会影响异基因造血干细胞移植后供体来源克隆的扩增——一项虚拟临床试验。
Front Immunol. 2024 Dec 16;15:1321336. doi: 10.3389/fimmu.2024.1321336. eCollection 2024.
2
Dynamically adjusted cell fate decisions and resilience to mutant invasion during steady-state hematopoiesis revealed by an experimentally parameterized mathematical model.通过一个经过实验参数化的数学模型揭示了在稳态造血过程中动态调整的细胞命运决定和对突变体入侵的恢复能力。
Proc Natl Acad Sci U S A. 2024 Sep 17;121(38):e2321525121. doi: 10.1073/pnas.2321525121. Epub 2024 Sep 9.
3

本文引用的文献

1
Age-Related Macular Degeneration in Patients With Chronic Myeloproliferative Neoplasms.慢性骨髓增殖性肿瘤患者的年龄相关性黄斑变性
JAMA Ophthalmol. 2017 Aug 1;135(8):835-843. doi: 10.1001/jamaophthalmol.2017.2011.
2
Emergence of heterogeneity in acute leukemias.急性白血病中异质性的出现。
Biol Direct. 2016 Oct 12;11(1):51. doi: 10.1186/s13062-016-0154-1.
3
A 7-Gene Signature Depicts the Biochemical Profile of Early Prefibrotic Myelofibrosis.一种7基因特征描绘了早期纤维化前骨髓纤维化的生化特征。
Mathematical modelling of stem and progenitor cell dynamics during ruxolitinib treatment of patients with myeloproliferative neoplasms.在治疗骨髓增殖性肿瘤患者的芦可替尼治疗过程中,对干细胞和祖细胞动力学的数学建模。
Front Immunol. 2024 May 7;15:1384509. doi: 10.3389/fimmu.2024.1384509. eCollection 2024.
4
Computational modeling reveals key factors driving treatment-free remission in chronic myeloid leukemia patients.计算建模揭示了慢性髓性白血病患者实现无治疗缓解的关键驱动因素。
NPJ Syst Biol Appl. 2024 Apr 27;10(1):45. doi: 10.1038/s41540-024-00370-4.
5
Investigation of Serum Albumin as a Dynamic Treatment-Specific Surrogate for Outcomes in Patients With Myelofibrosis Treated With Ruxolitinib.探讨血清白蛋白作为芦可替尼治疗骨髓纤维化患者的动态治疗特异性替代终点与结局的关系。
JCO Precis Oncol. 2024 Mar;8:e2300593. doi: 10.1200/PO.23.00593.
6
Inherited polygenic effects on common hematological traits influence clonal selection on JAK2 and the development of myeloproliferative neoplasms.遗传多基因效应对常见血液学特征的影响影响 JAK2 的克隆选择和骨髓增殖性肿瘤的发展。
Nat Genet. 2024 Feb;56(2):273-280. doi: 10.1038/s41588-023-01638-x. Epub 2024 Jan 17.
7
Mutations, inflammation and phenotype of myeloproliferative neoplasms.骨髓增殖性肿瘤的突变、炎症与表型
Front Oncol. 2023 May 22;13:1196817. doi: 10.3389/fonc.2023.1196817. eCollection 2023.
8
The multidisciplinary approach to eosinophilia.嗜酸性粒细胞增多症的多学科治疗方法。
Front Oncol. 2023 May 18;13:1193730. doi: 10.3389/fonc.2023.1193730. eCollection 2023.
9
Contributions of bone marrow monocytes/macrophages in myeloproliferative neoplasms with JAK2 mutation.骨髓单核细胞/巨噬细胞在 JAK2 突变的骨髓增殖性肿瘤中的作用。
Ann Hematol. 2023 Jul;102(7):1745-1759. doi: 10.1007/s00277-023-05284-5. Epub 2023 May 26.
10
Serum levels of IL-4, IL-13 and IL-33 in patients with age-related macular degeneration and myeloproliferative neoplasms.血清中白细胞介素-4、白细胞介素-13 和白细胞介素-33 在年龄相关性黄斑变性和骨髓增生性肿瘤患者中的水平。
Sci Rep. 2023 Mar 11;13(1):4077. doi: 10.1038/s41598-023-31078-w.
PLoS One. 2016 Aug 31;11(8):e0161570. doi: 10.1371/journal.pone.0161570. eCollection 2016.
4
Metastasis: new functional implications of platelets and megakaryocytes.转移:血小板和巨核细胞的新功能意义。
Blood. 2016 Jul 7;128(1):24-31. doi: 10.1182/blood-2016-01-636399. Epub 2016 May 6.
5
Myeloproliferative neoplasms and inflammation: whether to target the malignant clone or the inflammatory process or both.骨髓增殖性肿瘤与炎症:靶向恶性克隆还是炎症过程,或者两者兼而有之。
Leukemia. 2016 May;30(5):1018-24. doi: 10.1038/leu.2016.12. Epub 2016 Feb 8.
6
Antecedent cardiovascular disease and autoimmunity in Philadelphia-negative chronic myeloproliferative neoplasms.费城染色体阴性慢性骨髓增殖性肿瘤中的既往心血管疾病和自身免疫
Leuk Res. 2016 Feb;41:27-35. doi: 10.1016/j.leukres.2015.11.017. Epub 2015 Dec 2.
7
Survival of patients with chronic myeloproliferative neoplasms and new primary cancers: a population-based cohort study.慢性骨髓增殖性肿瘤患者与新发原发性癌症患者的生存情况:一项基于人群的队列研究。
Lancet Haematol. 2015 Jul;2(7):e289-96. doi: 10.1016/S2352-3026(15)00092-7. Epub 2015 Jun 11.
8
Mediators of Inflammation in Myeloproliferative Neoplasms: State of the Art.骨髓增殖性肿瘤中的炎症介质:最新进展
Mediators Inflamm. 2015;2015:964613. doi: 10.1155/2015/964613. Epub 2015 Nov 23.
9
Inflammation as a Keystone of Bone Marrow Stroma Alterations in Primary Myelofibrosis.炎症作为原发性骨髓纤维化中骨髓基质改变的关键因素。
Mediators Inflamm. 2015;2015:415024. doi: 10.1155/2015/415024. Epub 2015 Nov 12.
10
MPNs as Inflammatory Diseases: The Evidence, Consequences, and Perspectives.骨髓增殖性肿瘤作为炎症性疾病:证据、后果及展望
Mediators Inflamm. 2015;2015:102476. doi: 10.1155/2015/102476. Epub 2015 Oct 28.